vilanterol trifenatate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
9 FDA-registered drug labelers
Glaxo Operations UK Ltd
Glaxo Wellcome Manufacturing Pte. Ltd
GlaxoSmithKline LLC
MSN Laboratories Private Limited
Prasco Laboratories
Sterling Chemical Malta Ltd
STERLING SPA
TAPI Czech Industries s.r.o.
Teva Czech Industries s.r.o
Why It Matters
Sectors
Health
Downstream Uses
Appears in 5 drug and cosmetic product listings (FDA).
- •Breo Ellipta
- •Fluticasone Furoate and Vilanterol
- •Anoro Ellipta
- •Trelegy Ellipta
- •Umeclidinium and Vilanterol Ellipta
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS503070-58-4
PubChem CID44482554
DTXSIDDTXSID80659232
FormulaC44H49Cl2NO7
Mol. Weight774.8 g/mol
SMILESC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl
Data Sources
444825542026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/vilanterol trifenatate/cids/JSON
Archive: data/sources/pubchem_name/vilanterol trifenatate.json
CAS 503070-58-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json